Teva Pharmaceutical Industries reported $2.16B in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Aspen Pharmacare ZAR 12.34B 739M Jun/2024
Cipla INR 8B 1.22B Mar/2025
Dr.Reddys Laboratories INR 9B 5.65B Jun/2025
Guangzhou Baiy CNY 14.51B 14.51B Mar/2025
Jiangsu Hengrui CNY 36.12B 12.04B Jun/2025
Kalbe Farma IDR 3.8T 715.05B Jun/2025
Richter Gedeon HUF 135.63B 61.59B Dec/2024
Sh Fosun Pharma CNY 12.96B 757.22M Jun/2025
Sun Pharmaceuticals INR 113.32B 33.19B Mar/2025
Teva Pharmaceutical Industries USD 2.16B 464M Jun/2025